March 24, 2015 / President's Message
Over the past several days we have achieved major advancement in the ability of interventional cardiologists to care for higher-risk patients who have limited options through conventional therapies (medical or surgical). A combination of approvals from the Food & Drug Administration and new data announced during ACC.15 have expanded both the knowledge and tools we can use to provide therapies shown to save lives and enhance quality of life. Summarized below are recent advancements that interventional cardiologists and our Heart Teams can use to deliver optimal care for our patients. Keep reading.
March 24, 2015 / SCAI 2015 News
This year, as part of a major theme running through its educational sessions, SCAI 2015 will feature a brand-new opening session on State-of- the-Art Technologies. The session will include two presentations, given by Christian Assad-Kottner, MD, and by Peter J. Fitzgerald, MD, PhD, each examining how potentially disruptive technology may impact invasive/interventional cardiology. Continue reading.
March 24, 2015 / Press Release
As congenital heart disease (CHD) treatment advances, children with these conditions are living into adulthood, and over time, they may need additional treatment. A new expert consensus paper released today by the Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) provides guidance on transcatheter pulmonic valve replacement, or tPVR, for children and adults who were previously treated for CHD. Continue reading.
February 28, 2015 / President's Message
I’m writing to share news about some important new resources that you’ll want to take advantage of. First, just posted on SCAI.org is a brand-new FAQ tool that addresses the questions that you and your billing staff may have about CMS’s new specialty designation for Interventional Cardiology. In case you missed it, this is a big step forward for our specialty because, once you change your designation in the CMS database, your Medicare claims will be less likely to be denied as “duplicates” of services provided by other physicians in your practice who are not interventionalists. The new designation should also help all of us improve how our services are perceived with regard to resource utilization and outcomes. By identifying ourselves as Interventional Cardiologists (rather than as Cardiologists) we help eliminate apples-to-oranges comparisons with other physicians whose work is less intense and whose patients are often less complex. Keep reading.
February 23, 2015 / Press Release
Today the Society for Cardiovascular Angiography and Interventions (SCAI) announced the selection of 12 early-career interventional cardiologists to participate in the 2015-17 Emerging Leader Mentorship (ELM) Program, a collaborative program developed in 2010 by SCAI in partnership with the American College of Cardiology (ACC) and Cardiovascular Research Foundation (CRF). These promising young physicians will participate in an intense, hands-on, two-year mentorship program to improve and refine their skills as leaders in medicine, ambassadors for their specialty and advocates for their patients. Find out who made the cut.
February 17, 2015 / Press Release
– Increasingly, physicians and scientists are discovering the complex connections among genes in the body that influence disease. These discoveries will enable personalized treatments in an emerging area of science known as network medicine. In his upcoming Mullins Lecture at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions, “Network Medicine: A Systems Approach to Cardiovascular Disease Diagnosis and Management,” Joseph Loscalzo, MD, PhD, Chairman of the Department of Medicine, Physician-in-Chief of Brigham and Women’s Hospital, and Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School, will discuss how advances in big data are enabling the new field of network medicine to uncover the complex pathways that influence disease. Continue reading.